203 related articles for article (PubMed ID: 30854093)
1. MYH9 Promotes Growth and Metastasis via Activation of MAPK/AKT Signaling in Colorectal Cancer.
Wang B; Qi X; Liu J; Zhou R; Lin C; Shangguan J; Zhang Z; Zhao L; Li G
J Cancer; 2019; 10(4):874-884. PubMed ID: 30854093
[TBL] [Abstract][Full Text] [Related]
2. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
[TBL] [Abstract][Full Text] [Related]
3. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
4. The Overexpression of NMHC IIA Promoted Invasion and Metastasis of Nasopharyngeal Carcinoma Cells.
Xiong D; Chen D; Liu D; Wu W; Dou X; Ji X; Li J; Zhang X
J Cancer; 2021; 12(14):4218-4228. PubMed ID: 34093822
[No Abstract] [Full Text] [Related]
5. S100A4-MYH9 Axis Promote Migration and Invasion of Gastric Cancer Cells by Inducing TGF-β-Mediated Epithelial-Mesenchymal Transition.
Li F; Shi J; Xu Z; Yao X; Mou T; Yu J; Liu H; Li G
J Cancer; 2018; 9(21):3839-3849. PubMed ID: 30410586
[TBL] [Abstract][Full Text] [Related]
6. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
[TBL] [Abstract][Full Text] [Related]
7. LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition.
Wang B; Zhang L; Zhao L; Zhou R; Ding Y; Li G; Zhao L
Cell Commun Signal; 2017 Jun; 15(1):21. PubMed ID: 28606091
[TBL] [Abstract][Full Text] [Related]
8. MYH9-dependent polarization of ATG9B promotes colorectal cancer metastasis by accelerating focal adhesion assembly.
Zhong Y; Long T; Gu CS; Tang JY; Gao LF; Zhu JX; Hu ZY; Wang X; Ma YD; Ding YQ; Li ZG; Wang XY
Cell Death Differ; 2021 Dec; 28(12):3251-3269. PubMed ID: 34131310
[TBL] [Abstract][Full Text] [Related]
9. MYH9 suppresses melanoma tumorigenesis, metastasis and regulates tumor microenvironment.
Singh SK; Sinha S; Padhan J; Jangde N; Ray R; Rai V
Med Oncol; 2020 Sep; 37(10):88. PubMed ID: 32902730
[TBL] [Abstract][Full Text] [Related]
10. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
[TBL] [Abstract][Full Text] [Related]
11. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
[TBL] [Abstract][Full Text] [Related]
12. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
[TBL] [Abstract][Full Text] [Related]
13. TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways.
Yang RW; Zeng YY; Wei WT; Cui YM; Sun HY; Cai YL; Nian XX; Hu YT; Quan YP; Jiang SL; Wang M; Zhao YL; Qiu JF; Li MX; Zhang JH; He MR; Liang L; Ding YQ; Liao WT
J Exp Clin Cancer Res; 2016 Sep; 35(1):152. PubMed ID: 27669982
[TBL] [Abstract][Full Text] [Related]
14. UCHL3 promotes proliferation of colorectal cancer cells by regulating SOX12 via AKT/mTOR signaling pathway.
Li J; Zheng Y; Li X; Dong X; Chen W; Guan Z; Zhang C
Am J Transl Res; 2020; 12(10):6445-6454. PubMed ID: 33194042
[TBL] [Abstract][Full Text] [Related]
15. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of CD147 promotes cell invasion, epithelial-to-mesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer.
Xu T; Zhou M; Peng L; Kong S; Miao R; Shi Y; Sheng H; Li L
Int J Clin Exp Pathol; 2014; 7(11):7432-41. PubMed ID: 25550778
[TBL] [Abstract][Full Text] [Related]
17. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition.
Shi C; Yang X; Bu X; Hou N; Chen P
Biochem Biophys Res Commun; 2017 Aug; 489(4):369-374. PubMed ID: 28506831
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
[TBL] [Abstract][Full Text] [Related]
19. STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer.
Zhang Z; Liu X; Feng B; Liu N; Wu Q; Han Y; Nie Y; Wu K; Shi Y; Fan D
Oncogene; 2015 Sep; 34(37):4808-20. PubMed ID: 25531324
[TBL] [Abstract][Full Text] [Related]
20. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
